Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral phosphonous bis-amino-oxazoline copper complex enables 98% yield in Henry reactions, offering reliable pharmaceutical intermediate supply.
Advanced asymmetric hydrogenation technology for optically active aldehydes and ketones. Reliable fragrance intermediate supplier offering cost-effective, scalable manufacturing solutions.
Patent CN103539827B details high-yield thiooligosaccharide synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN108623494B details a green photocatalytic method for synthesizing imines using sulfur-containing aza metalloporphyrin, offering high selectivity and cost reduction.
Novel enzymatic route for (2S,3R)-p-methylsulfonylphenylserine ethyl ester eliminates copper waste and resolution steps, offering cost-effective API intermediate supply.
Patent CN102888431A reveals high-concentration enzymatic synthesis for L-tert-Leucine, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115850048B reveals metal-free HBeta zeolite catalysis for 2-aryl butenones. Delivers high purity, water-based solvent systems, and significant supply chain cost optimization.
Patent CN102728407B details a waste-utilizing synthesis for chiral salen catalysts, offering cost reduction in pharmaceutical intermediate manufacturing via single-solvent processes.
Patent CN113149865B reveals a metal-free mPMF catalyst for efficient ethyl α-cyanocinnamate production, offering superior selectivity and cost reduction in pharma intermediate manufacturing.
Patent CN105543186A reveals novel biocatalytic route for high-purity chiral alcohols. Enables cost reduction in chiral alcohol manufacturing and supply chain reliability.
Patent CN105543186A enables high-purity chiral alcohol production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN116904411A reveals mutant enzyme for efficient (R)-citronellal synthesis. Offers high ee value and conversion for reliable flavor and fragrance supplier needs.
Patent CN104447697A reveals a novel enzymatic route for Dabigatran intermediates, offering high purity and cost-effective supply chain solutions for global pharmaceutical manufacturers.
Patent CN120843624A reveals high-efficiency biocatalytic synthesis. Achieves 99% conversion and ee value. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112538506A details a novel lipase-catalyzed route for Chloramphenicol Succinate, offering higher purity, reduced toxicity, and scalable manufacturing for global supply chains.
Patent CN114621985B reveals enzymatic synthesis breakthrough. Delivers high purity and supply chain reliability for global pharmaceutical intermediate procurement strategies.
Patent CN114621986B reveals enzymatic synthesis for optically pure Taxol side chains. Discover cost-effective, scalable manufacturing solutions for pharmaceutical intermediates.
Patent CN105985290B reveals oxidant-free visible light photocatalysis for isoquinoline derivatives. This method ensures high purity and supply chain stability for pharmaceutical intermediates manufacturing.
Novel low-temperature synthesis for DiDOPO-A reduces corrosion and cost. Reliable supply chain for high-purity flame retardant intermediates with scalable production capacity.
Patent CN118126972A reveals acid-resistant carbonyl reductase mutant for efficient (S)-NBHP synthesis, offering significant cost reduction and supply chain reliability.